TRialing individualized interventions to prevent functional decline in at-risk older adults (TRIIFL): study protocol for a randomized controlled trial nested in a longitudinal observational study by Grimmer, K. et al.
PUBLISHED VERSION  
 
Karen Grimmer, Julie Luker, Kate Beaton, Saravana Kumar, Alan Crockett and Kay Price 
TRialing individualized interventions to prevent functional decline in at-risk older adults (TRIIFL): 
study protocol for a randomized controlled trial nested in a longitudinal observational study 
Trials, 2013; 14(1):1-10 
© 2013 Grimmer et al.; licensee BioMed Central Ltd. This is an Open Access article distributed under 
the terms of the Creative Commons Attribution License 
(http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and 
reproduction in any medium, provided the original work is properly cited. 































Grimmer et al. Trials 2013, 14:266
http://www.trialsjournal.com/content/14/1/266STUDY PROTOCOL Open AccessTRialing individualized interventions to prevent
functional decline in at-risk older adults (TRIIFL):
study protocol for a randomized controlled trial
nested in a longitudinal observational study
Karen Grimmer1, Julie Luker1*, Kate Beaton1, Saravana Kumar1, Alan Crockett2 and Kay Price3Abstract
Background: Functional decline (FD) is a largely preventable feature of aging, characterized as gradual erosion of
functional autonomy. This reduces an older person’s capacity for safe, independent community living. The
healthcare needs of an unprecedented aging population places pressure on health systems to develop innovative
approaches to ensuring older people live healthy and independent lives for as long as possible.
TRIIFL aims to demonstrate that:
1. Incipient FD in older people can be identified using a simple telephone-screening process within four weeks
of discharge from an emergency department presentation for a minor health event; and
2. Early engagement into a person-centered individualized intervention arrests or reduces the rate of FD over the
next 12 months.
Methods/Design: A randomized controlled trial (RCT) nested within a 13-month longitudinal cohort study. The RCT
(conducted over 12 months) tests the effectiveness of a novel, early, home-based, personalized program (compared
with no intervention) in arresting or slowing FD.
TRIIFL focuses on older adults living independently in the community, who have not yet had a serious health event,
yet are potentially on the cusp of FD. Participants in the longitudinal cohort study will be recruited as they present
to one large tertiary hospital Emergency Department, providing they are not subsequently admitted to a ward.
Sample size calculations indicate that 570 participants need to be recruited into the longitudinal study, with 100
participants randomized into the trial arms.
Measures from all subjects will be taken face-to-face at baseline (recruitment), then subsequently by telephone at
one, four, seven and thirteen months later. Measures include functional abilities, quality of life, recent falls, mobility
dependence, community supports and health service usage. Specific to the nested RCT, the quality of life tool
(SF12) applied at one month, will identify individuals with low mental component quality of life scores, who will be
invited to enter the RCT.
Assessors will be blinded to RCT arm allocation, and subjects in the RCT will be blinded to the intervention being
received by other subjects.
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1. To determine whether an individualized early
intervention for community-dwelling older people
with poor mental component quality of life scores
measured one month after discharge directly from a
hospital emergency department (ED), reduces their
likelihood and/or rate, of functional decline (FD)
over the next twelve months.
2. To demonstrate that:
a. Incipient FD in an older person can be identified
within four weeks of discharge from an ED
presentation for a minor health event, using
lower than median mental component quality of
life scores; and
b. Engaging these older people early, into a person-
centered home-based intervention, arrests or
reduces the rate of FD over the next 12 months.Background
The immediate future presents Australian and global
health policy challenges in how to meet the health needs
of an aging population of unprecedented size [1]. Pre-
vention rather than treatment is a critical requirement.
The potential for FD with increasing age is outlined by
Edwards et al. [2], who illustrated that with age, an in-
creasing number of people are classified as below the
‘disability threshold’, putting them at significant risk of
preventable health crises such as falls, malnutrition and/
or infections. In 1950, less than 1% of the global popula-
tion was over 80 years old, but by 2050 this proportion
is expected to be 4%. The greatest increase will be in Or-
ganisation for Economic Co-operation and Development
(OECD) countries where the portion of the population
over 80 years old is expected to increase from an average
4% to 9.4% [1]. In Australia the number of people 85
years + will quadruple from 0.4 million in 2010 to 1.8
million in 2050 [3]. In 2009 to 2010, Australian govern-
ment spending on aged care was around $11 billion; two
thirds of that was in residential aged care [4]. Institu-
tional care use and acute care support needs of older
people will place commensurate pressure on health sys-
tems to develop innovative new approaches to ensuring
older people live healthy and independent lives for as
long as possible [1].
Functional decline
FD is a largely preventable feature of aging, characte-
rized as gradual erosion of functional autonomy, which
reduces an older person’s capacity to live safely and in-
dependently in the community [5-7]. FD encompasses
both physical and cognitive function. It is commonly
accepted that FD precedes frailty [8]; however, there
is no standard approach for defining or measuring eitherstate [8,9]. Reduced functional ability is associated
with increased mortality and morbidity rates, increased
use of health services in all sectors and greater rates of
institutionalization [7,10,11].
There are a number of Australian federal and state
health and aged care service initiatives to support ‘aging
in place’, aiming to optimize older people’s health, dignity,
confidence, self-esteem and independence. However, these
initiatives largely center on older people ‘known to the
system’ [12]. Many older people on the cusp of FD do not
come to the attention of healthcare providers until they
are in health and/or social crisis [2], and by then it may be
too late for effective intervention. Even individuals who
are already receiving community services at home, such as
Government-funded community care packages, may not
be receiving the care required to prevent FD [13].
The current lack of focus on early FD results from:
a) the lack of comprehensive primary health capture
points where older people are routinely screened for func-
tional and cognitive capacity; b) no comprehensive, timely
or sensitive screening tool to identify older people with
incipient FD; and c) no early-intervention program which
has been shown to have long term effectiveness to pre-
vent, or slow, the rate of, FD.
The importance of detecting FD after an ED presentation
Evaluation of recent changes to the way that general
medical practitioner (GP) services are being provided in
Australia (for example, by large corporate health services
or in multidisciplinary community clinics) suggest that
many older people now do not have regular contact with
the same GP [14,15]. This potentially attenuates oppor-
tunities for regular monitoring of older persons’ func-
tional abilities or flagging the need for intervention
before FD becomes critical. In Australia, decreasing op-
portunities and incentives to maintain contact with a
regular GP may be related to the increasing number of
frail, community-dwelling older people who appear to
rely on hospital EDs for crisis health management [16].
These individuals often do not require admission to hos-
pital for acute care. Rather, their needs are more for health
assessment and short-term management strategies and for
linkages to appropriate community supports to assist
them to maintain safe community independence in the
longer term. Thus, whether or not it is the right place, ED
attendance without a subsequent hospital admission, is an
increasingly important service-contact point related to
incipient FD.
How is FD detected?
FD generally occurs subtly and can remain undetected
until an unexpected and often catastrophic event occurs
[6]. This can be a fall or unexplained ill health which
requires hospitalization. This event, if followed by a
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an individual’s loss of capacity to function safely and inde-
pendently [6,7,17].
There are a variety of ways of assessing FD; however, it
is most commonly assessed as the capacity to complete
basic and instrumental activities of daily living (ADLs
and iADLs). Basic ADLs are everyday tasks (bathing,
dressing, feeding, continence, transferring, toileting)
[18], while iADLs are higher level activities (shopping,
driving, banking and so on) [19,20]. Inability to manage
ADLs safely and independently may only be temporary,
if related to illness. This will usually respond well to re-
covery time and short-term targeted intervention. FD,
however, may be irreversible if identified too late for
effective community-based interventions. Individuals
who have passed the critical threshold of FD may not be
able to live safely at home despite intensive and long-
term supports and, thus, may require permanent resi-
dential care. Irrespective of the point at which FD is
assessed on its trajectory, there is no agreement on the
best measures to detect FD nor the point of critical de-
terioration [21].
Detecting FD early and putting supports in place, as
directed by the older person, to redress specific and indi-
vidual areas of decline has been proposed as a way of
maintaining older people’s community independence for
a longer time [17,22-25]. Comprehensive frailty indices
with multiple screening items have also been proposed
from population research, mainly conducted in the UK
and Canada [6,21,26,27]. However, there are few oppor-
tunities in Australia comprehensively to capture this
amount of information from community-dwelling older
people who are not in health crisis and who may not
routinely come to the attention of the healthcare system.
FD screening tools reported in the Australian literature
are implemented at ‘point-in-time’, commonly during a
health crisis at an ED presentation or hospitalization
[28]. In these environments, assessment of FD may be
inappropriate, when older people are unwell, disoriented,
frightened and/or in unfamiliar environments. This
raises issues of validity of assessment and/or reliability
of responses.
Pilot work underpinning this protocol
The TRIIFL study builds on 15 years of research into
improving the quality of discharge planning for older
people, to ensure that older people were transferred
safely from ill health in a hospital bed to health at home
[25,28-36]. Our work has highlighted common barriers
of lack of ownership and collective responsibility for the
problem, lack of time, poor communication and re-
sources, and hospital/community ‘turf wars’. Sadly there
have been no real changes in discharge planning stan-
dards or outcomes in Australia over this time.We recently published findings from an innovative
longitudinal pilot study we conducted in 2011, into pre-
diction and downstream assessment of FD in older
people presenting to, and being discharged from, a large
South Australian tertiary hospital ED [37]. This study
used a comprehensive data collection process to recruit
individuals who were not admitted to a hospital ward,
that is, they were discharged directly from ED usually
within four to eight hours of presentation. This work
clearly showed that ED was the choice for 30 to 60 older
people/day, who were eligible for our study and did not
have their own GP. In our pilot study, we followed up
subjects at one week and one and three months later to
follow the course of FD. Estimated likelihood of FD at
discharge was made with a comprehensive purpose-built
assessment tool, as well as the Hospitals Admission
Risk Profile (HARP) instrument [36]. We reported
that overall, the likelihood of FD at discharge appro-
ximated 50%, significantly more than the 30% pre-
dicted in the Australian Discharge of Elderly from the
Emergency Department (DEED) study [38]. Of note in the
2011 pilot study was the percentage of ‘younger’ old
patients (65 to 75 years old) who had significant risk of
FD, despite attracting no age weighting from the HARP
instrument.
The TRIIFL protocol is based on a novel finding from
this pilot research, that subjects with lower than median
mental component scores (MCS) on the Short Form-12
Health Survey (SF12) quality of life instrument [39,40],
administered one month post-discharge from the ED,
were significantly more likely to demonstrate FD two
months later (identified as significant reduction in iADL
scores, increased falls and hospitalizations), compared
with individuals with above-median MCS scores at the
same time point. We propose that if early intervention
was offered to individuals with low mental health quality
of life scores at this point in time, progression of FD
could be altered.
Summary
Identifying and effectively reducing FD in community-
dwelling older Australians is of significant interest to
policy makers and clinicians. To date, there is no valid
or reliable way of identifying FD in any setting, and FD
identification usually occurs at crisis health presentations
to hospital, rather than in community health settings
under ‘usual’ circumstances. Thus, many individuals go
undetected, until their capacity to live independently
and safely in the community is in question. Our research
is the first that we know of, to propose that a real risk of
downstream FD in an older person can be identified
within four weeks of an ED presentation for a minor
health event, using low mental quality of life scores. We
further propose that early community-based interventions
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delay its onset.Current status
A competitive national grant application has been made
to support project funding for two years from 2014.Methods
Study design
TRIIFL is a randomized controlled trial (RCT) nested in
a 13-month longitudinal cohort study (Figure 1).Figure 1 Study design – RCT nested in a longitudinal cohort study.Study 1: Longitudinal cohort study
The total sample is recruited in Study 1. Every partici-
pant will be assessed for FD outcomes and predictors
over the following 13 months (at five time points) using
a battery of tests.Setting, timing
Eligible individuals will be recruited from the ED of a
large metropolitan hospital in Adelaide, South Australia,
between April and June 2014, using the recruitment
process successfully piloted in our 2011 study [37].
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Inclusions
 65 years old or older
 Presented to ED with non-catastrophic health
conditions which do not result in admission to
hospital for further care
Exclusions
 Suffering communicable diseases requiring isolation
 Current mental health crisis
 Under detention
 Diagnosis of dementia
 Unable to communicate in English
 Profoundly deaf (such as would limit telephone
communication at follow-up)
To remain eligible for the study, individuals must not
subsequently become an inpatient as a result of the
index ED presentation (that is, must be discharged dir-
ectly to home from ED). Subsequent hospital admissions
and/or ED presentations (unrelated to the index ED
presentation) do not compromise eligibility, as this infor-
mation, captured at each follow-up, is important to build
a service-usage profile. Being a ‘frequent flyer’ to ED
does not compromise eligibility, as these individuals may
well be on the cusp of FD and are not detected, despite
multiple ED presentations.
Baseline screening
We will collect data in the ED (baseline) on consenting,
eligible participants from
 the electronic hospital admissions system - age,
gender, residential details, differential diagnosis; and
 a test battery as successfully piloted in our 2011
study [37]. This captures the highest level of
schooling, primary language, ED presentations and
hospitalizations in the past six months, falls in the
past twelve months using the Falls Risk in Older
People - Community (FROP_COM) instrument [39],
living arrangements, requiring a carer, receiving
community services, type and use of gait aid, iADLs
[19] and cognition with the Mini Mental State
Examination (MMSE) [40].
Based on data from our pilot study, we will addition-
ally apply the Katz et al. [18] 20 basic ADL instrument
and two quality of life measures – the SF12 [41,42] and
the Australian Quality of Life (AQoL 4D) [43]. By
collecting both basic and iADL scores, we can provide
comprehensive ADL information about the target popu-
lation to compare with international data. The SF12 pro-
vides the opportunity for international population-based
comparisons of quality of life [41,42] with our sample ofolder ED presenters. The AQoL, which has not previ-
ously been used for older people discharged from ED,
provides an Australian perspective on health-related
multi-attribute utility quality of life [43], and allows
production of health cost effectiveness data (quality-
adjusted life years (QALYs)), and estimation of burden
of disease.
This total test battery takes an average of 5.5 minutes
to administer. All but two questions are delivered ver-
bally by the recruiting researcher, who records the an-
swers. The older person only has to write responses to
two MMSE questions.
Outcome measures
At one, four, seven and thirteen months after recruit-
ment, all participants will be contacted by telephone and
consent sought for interview. Socio-demographic infor-
mation will be confirmed, and all outcome instruments
and mutable independent variables will be recorded
(Table 1). Semi-structured questions will be asked about
how participants are managing, their concerns and rea-
sons for subsequent hospitalizations and ED presenta-
tions. At the four, seven and thirteen month data
collection points (after nested RCT commencement), as-
sessors will be blinded to group allocation.
Additional data and calculations
From baseline information on age, iADLs and MMSE
scores, a HARP score will be determined [17,36]. HARP,
while sensitive to approximately 63% only, is useful for
comparing FD risk in our sample with other Australian
and international studies. Validation details of the index
ED presentation will be undertaken via patient record
audit to verify age, presenting diagnosis, previous hospi-
talizations and ED discharge plans (if any).
Study 1 analysis
FD will be assessed as change from baseline at each time
point as:
 One or more falls increase from the baseline rate
 More than one event of hospitalization, or ED
presentation, from the baseline rate
 Decrease of one point in any item of the ADL
instrument [18], or
 Decrease of 2+ points from baseline total iADL
score [19], or any decrease in baseline score in
the domains of home activities, doing laundry,
shopping and getting places (we previously
reported these domains as critical to functional
independence) [37]
 Scores decreasing from above median at baseline in
either physical or mental domain, to below median
in the SF12 [41,42]
Table 1 Timeframes of outcome measurements
Measures Baseline 1 month 4 months 7 months 13 months
ADLs √ √ √ √ √
iADLs √ √ √ √ √
SF12 √ √ √ √ √
AQoL_4D √ √ √ √ √
Falls √ (last 12 months) √ (last month) √ (last 3 months) √ (last 3 months) √ (last 6 months)
Hospitalizations √ (last 6 months) √ (last month) √ (last 3 months) √ (last 3 months) √ (last 6 months)
Gait aid (type) √ √ √ √ √
Living arrangements √ √ √ √ √
Carer engagement √ √ √ √ √
Organized (formal) community services √ √ √ √ √
GP visits √ √ √ √ √
Informal community supports √ √ √ √ √
Satisfaction with community supports √ √ √ √ √
ADLs, activities of daily living; AQoL_4D, Australian Quality of Life; GP, general practitioner; iADLs, instrumental activities of daily living; SF12, Short Form-12 Health
Survey; √ indicates an occasion of data collection.
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described for chronic obstructive pulmonary disease
(COPD))[44]
 Change to a more assistive gait aid (for example, a
one point stick to a four-pronged stick)
 Change in living arrangements to more supported
care
 Increased carer involvement
 Greater type and frequency of use of formal
community services or informal supports
 More frequent GP attendances.Study 2: nested RCT
Subject selection and randomization
All participants in Study 1 will be stratified at one-
month telephone follow-up into low and high scores on
the MCS domain of the SF-12, (SF12-MCS), using the
median cut point. We previously reported this as a
transformed score of 55 [37], which is comparable to the
same age-gender population SF-12 norms [41]. The
nested RCT will be conducted involving only the sub-
jects with lower than median SF12-MCS scores at this
time point (Figure 1).
An independent trials office will randomize these sub-
jects using a computer generated random number series,
into an individualized person-centered community-based
intervention, or ‘usual care’ which reflects no intervention.
It is unlikely that any intervention would normally be of-
fered to this population as it is not current practice to
screen people for low mental component quality of life
scores after an ED contact.Considering Studies 1 and 2, there are three study co-
horts (Figure 1):
 Subjects with SF12-MCS scores ≥55, who will be
observed only, for 13 months after recruitment (12
months after the one month SF12 scores are taken)
(the observed cohort)
 Subjects with SF12-MCS scores <55, from which
two RCT groups will be allocated one month after
recruitment, randomized into
 Intervention specifically tailored to address the
individual’s problems, concerns, and goals (low
SF12-MCS, intervention cohort)
 No treatment (low SF12-MCS, no treatment
cohort).
Outcome measures for the two RCT groups will be
taken at three-, six- and twelve-month time points after
randomization (four, seven and thirteen months post-
recruitment).
The intervention
The intervention arm applies a novel person-focused
home-based approach targeting individual need [45].
Patient/person-centered care has been defined by Berwick
[46] as ‘The experience (to the extent the informed, indi-
vidual patient desires it) of transparency, individualization,
recognition, respect, dignity, and choice in all matters,
without exception, related to one’s person, circumstances,
and relationships in health care’ [46,p2].
The intervention will be applied independently by a
large provider of community aged care in South Australia
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loped a patient-centered program for community-dwelling
older individuals considered by their GP to be at-risk of
declining functionally. The program involves a home as-
sessment and interview conducted by occupational thera-
pists or physiotherapists to identify individual problems
and concerns and to set appropriate goals. Care options
are discussed with older people and families in particular
individualized interventions, which could include atten-
dance at day therapy centers, exercise, fitness, balance-
retraining and/or socialization, organization of home help
or community care packages, motivational interviewing or
counseling. Transport to programs can also be provided
to increase compliance and reduce attendance barriers.
Programs can last three to fourteen weeks, depending
on need. The median/person cost of the intervention
approximates $2,100 (interquartile range (IQR) $350),
which approximates the cost of one acute South Australian
hospital bed-day.
Ethical issues
Written permission has been obtained from the Hospital
Executive and ED Management of the research site, and
ethical approval has been granted by the Human Research
Ethics Committee of the University of South Australia
(Application ID: 0000031475).
While there are indications from its early evaluation
data that the ECH intervention is acceptable to clients,
its effectiveness is largely unproven, particularly in indi-
viduals with low SF12-MCS scores at commencement.
We do not know that the intervention will provide any
advantage; in fact, individuals may perceive that they are
subjected to additional burdens, such as unwanted as-
sessments and visitors in their home for (perhaps) no
overall benefit. We see no disadvantage for the ‘control’
group (low SF12-MCS, no treatment cohort) at this
point in our understanding, in not being offered care,
nor not knowing that the intervention is available, as
they are currently not offered routine intervention so
early after an ED discharge. If ,however, at subsequent
follow-up points (three, six or twelve months), any par-
ticipant in the observed cohort arm or the low SF12-
MCS, no treatment arm is identified as potentially de-
monstrating FD on any study measure, the need for rescue
care will be suggested and ways to access this discussed.
This may include attendance at their GP or making
contact with local community service providers.
Sample size considerations
To date, there is scant research that has established the
effectiveness of any community-based person-centered
intervention program that alerts older people who are on
the cusp of FD to impending FD and provides means to
assist and support them. We drew the likely effectivenessof the proposed intervention program from research on
early intervention programs for at-risk older people who
are in hospital or rehabilitation units. This included an
Australian study [47] (significant improvement in goals
and functioning) and a Dutch study [48] (effect size 0.25).
We acknowledge that this research may not be readily
generalizable to estimate effectiveness of the intervention
in our reference population; however, it is the best avail-
able evidence for sample size calculation.
Our nested RCT study sample size was further calcu-
lated on minimal differences in iADLs and SF12 scores,
expected at three-month follow-up from our pilot data
[37]. These estimates are based on the three-month
follow-up distributions for iADLs and SF-12. Parameters
of power were set at π = 80% (1-β), with α = 5%. For
iADLs, we identified that a minimum absolute effect size
of 1.2 would be needed for participants to have dropped
by at most 1 point on the Lawton scale (the Lawton def-
inition of FD requires a drop of 2+ points on the scale).
Thus, a minimum sample size of NIADL = 50 per RCT
cohort would be required (total 100). For the MCS do-
main of SF-12, a minimum absolute effect size of 4.3
would need to be observed, to put all scores above or
equal to the median value, giving sample size of NMCS =
30 per RCT cohort (total 60). Similarly for the PCS do-
main of SF-12, the minimum absolute effect size of 12.2
gives a sample size of NPCS = 6 per RCT cohort (total
12). We require significance to be determined both clin-
ically and statistically, so over-sampling is not of concern
and, therefore, we choose the highest sample size
(NIADL) of N = 50 per RCT cohort (100 total) at three
months RCT follow-up (four months from ED recruit-
ment). Thus, our continuing RCT sample at three
months will reflect 100 individuals with low SF12-MCS
(randomized 50 each into intervention and control
arms), and 100 individuals with high SF12-MCS who will
simply be followed-up.
To provide the nested RCT cohort sample, there are
specific considerations which will influence the number
of individuals invited to participate in Study 1:
 Eligibility at time of recruitment (12% continuation).
 Consent at time of recruitment (30% continuation).
 Continuity through study (43% continuation).
 Study-designed attrition (estimated 10% attrition).
 Increased awareness of the study purpose, through
the previous successful relationship established
between the research team and the Royal Adelaide
Hospital (RAH) staff, regarding awareness of
detecting the risk of FD (estimated as improving the
capture rate of eligible individuals by 10%).
Thus, to provide a continuing sample of 200 total sub-
jects (with high and low SF12-MCS) at three months
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one-month assessment point of 220+ individuals; there-
fore we require a sample of 570 eligible consenting indi-
viduals recruited on discharge from ED. Based on
previous experience, this will take 14 weeks at the par-
ticipating hospital.
For the nested RCT, we also took into account an as-
sumed rate of refusal for the intervention of 1:10 indi-
viduals who are offered it. This figure is based on pilot
feedback from ECH, the intervention provider. We will
address a potential loss of power in our intervention
arm, which would occur if eligible subjects refused, by
replacing every second refuser in the intervention group
with an individual randomly selected from the control
group for the RCT, who was recruited at the same time
as the refuser. By replacing 1:2 refusers (as opposed to
1:1), this retains the balance in the two intervention
arms. We will also analyze the characteristics of the re-
fusers qualitatively, to identify whether they are different
from the individuals who agreed to participate in the
intervention.
Intention to treat analysis will be used when data are
missing. However, every effort will be made to minimize
missing data. For instance when subjects are unable to
be contacted at the agreed time for any one data collec-
tion point, we will note their data as missing; however,
reasons for loss to follow-up will be sought by making
further contact with the subject. If possible, replacement
telephone interviews will be conducted within days of the
missed appointment, to provide the missing information.
When subjects provide some data during the telephone
interview, but not all, reasons for missing information willFigure 2 Hypothesized FD outcomes for the study groups.be recorded, to determine the appropriateness of using
‘carry-forward last known value’.
Analysis of data from Studies 1 and 2
The three study cohorts will be assessed at time of alloca-
tion into a study arm (one-month after recruitment)
for homogeneity in key socio-demographic character-
istics and immutable factors (for example, gender, age,
schooling, postcode, diagnosis) and all outcome measures
(including the percentage of ‘frequent flyers’ in each arm).
We previously reported this as one or more ED contacts
per month over the preceding 12 months [33,34].
Change over time in each outcome measure will be
calculated using repeated measures analysis of variance
(ANOVA) models, with study contact point, cohort (1, 2,
or 3) and key demographic features as independent vari-
ables. Partial Least Squares (PLS) models using pathway
analysis will be applied to the multiple outcome, immut-
able and mutable independent variables at each time
point, to determine different spatial arrangements and the
significant factors which impact on data clusters.
Hypotheses
As shown in Figure 2, our hypothese are:
1. The observed cohort will not demonstrate FD over
the following 12 months in any FD measure.
2. The low SF12-MCS, no treatment cohort will
demonstrate significant FD in any one or more
outcome measures, taken over the next three
months, when compared to their baseline
recruitment status.
Figure 3 Timelines and tasks.
Grimmer et al. Trials 2013, 14:266 Page 9 of 10
http://www.trialsjournal.com/content/14/1/2663. The low SF12-MCS, intervention cohort will show
no FD (comparable findings to the observed cohort)
over the next 12 months.
4. Additionally, those individuals in the low SF12-MCS,
no treatment cohort who demonstrate significant
FD at three months follow-up, and who access
‘rescue’ intervention (see Section on Ethics), will
show an attenuated rate of FD over the following
twelve months, compared with the rate they
exhibited in the first three months.
Timelines
Based on our pilot work understanding of data collec-
tion issues, we have confidence that this project can be
conducted successfully over 24 months (Figure 3).
Outcomes and significance
Given the high and increasing costs of tertiary healthcare,
it is of increasing importance to communities and healthcare
budgets, that incipient FD is detected early and effectively
addressed. We propose that early sensitive screening coupled
with low cost, individually-targeted interventions will
save huge avoidable downstream health costs and as-
sist older people to live safely and independently for
longer at home.
The TRIIFL study aims to demonstrate that a simple
early screening phone call to older individuals after dis-
charge from ED to assess their physical and mental qua-
lity of life will identify those who are not coping (on the
cusp of FD). By referring them then, to cost-efficient
personalized community programs, significant improve-
ments can be made by arresting or slowing FD. This
research could shift Australian approaches to FD from
a reactive acute care mentality to a proactive colla-
borative preventive approach. The benefits, at a time of
diminishing public sector resources and increasing pres-
sure on aged care and acute services facing rising com-
plexity and demand, are considerable.Abbreviations
ADL: activities of daily living; AQoL_4D: Assessment of Quality of Life;
ED: emergency department; ECH: elderly citizens homes (the intervention
provider); FD: functional decline; FROP-COM: falls risk for older people-
community settings; GP: general practitioner; HARP: Hospitals Admission Risk
Profile; iADL: instrumental activities of daily living; MMSE: Mini Mental State
Examination; QALYs: Quality adjusted life years; RCT: randomized controlled
trial; SF12: Short Form-12 Health Survey; SF12-MCS: mental component
scores of the SF12.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KG was responsible for overall trial design and reporting, and leading the
pilot projects which preceded this protocol development. JL was responsible
for input into the trial design in terms of inclusion of appropriate literature,
and details on recruitment, sample size calculation and designing the
intervention. KB was responsible for the management of the pilot functional
decline project which preceded this protocol development, the literature
review underpinning this protocol, and for input into the sample size
calculation criteria. SK was responsible for input into the trial design and
input into the projects which preceded this protocol development.
AC was responsible for literature interpretation and input into the trial
design. KP was responsible for providing expert input into the aged care
system, in particular the intervention components and surrounding literature.
All authors read and approved the final manuscript.
Author details
1International Centre for Allied Health Evidence, University of South Australia,
GPO Box 2471, Adelaide, South Australia, Australia. 2Exercise for Health and
Human Performance, University of South Australia, Adelaide, South Australia,
Australia. 3Safety and Quality in Health Research Group, University of South
Australia, Adelaide, South Australia, Australia.
Received: 8 March 2013 Accepted: 6 August 2013
Published: 20 August 2013
References
1. Organisation for Economic Co-operation & Development: Help Wanted?
Providing and Paying for Long-Term Care. Paris: OECD Report; 2011.
2. Edwards P, Kalache A, Hoskins I, Keller I: Health and Ageing: A Discussion
Paper. Canada: WHO Discussion paper; 2002.
3. Aged Care Commissioner: Aged Care Commissioner Annual Report 1 July
2009–30 June 2010. Melbourne: Annual report; 2010.
4. Woods M, Fitzgerald R, Macri S: Caring for Older Australians: Final Inquiry
Report. Canberra: Report; 2011.
5. Hébert R: Functional decline in old age. CMAJ 1997, 157:1037–1045.
6. Rockwood K, Howlett SE, MacKnight C, Beattie BL, Bergman H, Hebert R,
Hogan DB, Wolfson C, McDowell I: Prevalence, attributes, and outcomes
Grimmer et al. Trials 2013, 14:266 Page 10 of 10
http://www.trialsjournal.com/content/14/1/266of fitness and frailty in community-dwelling older adults: report from the
Canadian Study of Health and Aging. J Gerontol A Biol Sci Med Sci 2004,
59:1310–1317.
7. Covinsky KE, Pierluissi E, Johnston CB: Hospitalization-associated disability:
“She was probably able to ambulate, but I’m not sure”. JAMA 2011,
306:1782–1793.
8. Bortz WM: Conceptual framework for frailty: a review. J Gerontol A Biol Sci
Med Sci 2002, 57:M283–M288.
9. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J,
Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA: Frailty in older
adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001,
56:M146–M146.
10. Fortinsky RH, Covinsky KE, Palmer RM, Landefeld CS: Effects of
functional status changes before and during hospitalization on
nursing home admission of older adults. J Gerontol A Biol Sci Med Sci
1999, 54:M521–M526.
11. Inouye S, Wagner D, Acampora D, Horwitz R, Cooney L, Hurst L, Tinetti M:
A predictive index for functional decline in hospitalized elderly medical
patients. J Gen Intern Med 1993, 8:645–652.
12. Australian Health Minister’s Advisory Council: Best Practice Approaches to
Minimise Functional Decline in the Older Person across the Acute, Sub-acute and
Residential Aged Care Settings: Update 2007. Melbourne: Clinical Epidemiology &
Health Service Evaluation Unit report, Melbourne Health; 2007.
13. Gordon C, Leigh J, Kay D, Humphries S, Tee K, Winch J, Thorne W:
Evaluation of the Consumer-directed Care Initiative: Final Report. Canberra:
Department of Health and Ageing report; 2012.
14. Sands LP, Xu H, Craig BA, Eng C, Covinsky KE: Predicting change in
functional status over quarterly intervals for older adults enrolled in the
PACE community-based long-term care program. Aging Clin Exp Res 2008,
20:419–427.
15. Infante F, Proudfoot J, Powell D, Bubner TK, Holton CH, Beilby JJ, Harris MF:
How people with chronic illnesses view their care in general practice: a
qualitative study. Med J Aust 2004, 181:70–73.
16. Joyce C, Piterman L: Trends in GP home visits. Aust Fam Physician 2008,
37:1039–1042.
17. Sager MA, Franke T, Inouye SK, Landefeld CS, Moragn TM, Rudburg MA,
Siebens H, Winograd CH: Functional outcomes of acute medical illness
and hospitalization in older persons. Arch Int Med 1996, 156:645–652.
18. Katz S, Ford AB, Moskowitz RW, Jackson BA, Jaffe MW: Studies of illness in
the aged: the index of ADL: a standardized measure of biological and
psychosocial function. JAMA 1963, 185:914–919.
19. Lawton M, Brody E: Assessment of older people: self-maintaining and
instrumental activities of daily living. Gerontologist 1969, 9:179–186.
20. Mehta KM, Yaffe K, Covinsky KE: Cognitive impairment, depressive
symptoms, and functional decline in older people. J Am Geriatr Soc 2002,
50:1045–1050.
21. Rockwood K, Mitnitski A: Limits to deficit accumulation in elderly people.
Mech Ageing Dev 2006, 127:494–496.
22. Ferrucci L, Guralnik JM, Studenski S, Fried LP, Cutler GB Jr, Walston JD:
Designing randomized, controlled trials aimed at preventing or delaying
functional decline and disability in frail, older persons: a consensus
report. J Am Geriatr Soc 2004, 52:625–634.
23. Wagner E: Preventing decline in function-evidence from randomized
trials around the world. West J Med 1997, 167:295–298.
24. Ellis G, Langhorne P: Comprehensive geriatric assessment for older
hospital patients. Br Med Bull 2004, 71:45–59.
25. Grimmer K, Moss J: The development, validity and application of a new
instrument to assess the quality of discharge planning activities from
the community perspective. Int J Qual Health Care 2001, 13:109–116.
26. Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I,
Mitnitski A: A global clinical measure of fitness and frailty in elderly
people. CMAJ 2005, 173:489–495.
27. Searle S, Mitnitski A, Gahbauer E, Gill T, Rockwood K: A standard procedure
for creating a frailty index. BMC Geriatr 2008, 8:24.
28. Sutton M, Grimmer-Somers K, Jeffries L: Screening tools to identify
hospitalised elderly patients at risk of functional decline: a systematic
review. Int J Clin Pract 2008, 62:1900–1909.
29. Barras S, Grimmer-Somers K, May E: Core criteria of an occupational
therapy home assessment: Delphi study of expert clinicians. J Eval Clin
Pract 2010, 16:1295–3000.30. Graumlich J, Grimmer-Somers K, Aldag J: Discharge planning scale:
community physicians’ perspective. J Hosp Med 2008, 3:455–464.
31. Grimmer K, Bowman P, Roper J: Episodes of allied health outpatient care:
an investigation of service delivery in acute public hospital settings.
Disabil Rehabil 2000, 22:80–87.
32. Grimmer KA, Moss JR, Gill TK: Discharge planning quality from the carer
perspective. Qual Life Res 2000, 9(9):1005–1013.
33. Grimmer K, Moss J, Falco J: Experiences of elderly patients regarding
independent community living after discharge from hospital:
a longitudinal study. Int J Qual Health Care 2004, 16:1–8.
34. Hedges G, Grimmer K, Moss J: Staff perceptions of discharge planning:
a challenge for quality improvement. Aust Health Rev 1999, 22:95–109.
35. Kimber CM, Grimmer-Somers KA: Multifaceted guideline implementation
strategies improve early identification and management of osteoporosis.
Aust Health Rev 2009, 33:423–433.
36. Sager MA, Rudberg MA, Jalaluddin M, Franke T, Inouye SK, Landefeld CS,
Siebens H, Winograd CH: Hospital admission risk profile (HARP):
identifying older patients at risk for functional decline following acute
medical illness and hospitalization. J Am Geriatr Soc 1996, 44:251–257.
37. Grimmer-Somers K, Beaton K, Young L, Kumar S, Hendry K, Moss J, Hillier S,
Forward J, Gordge L: Estimating risk of functional decline occurring after
discharge in elderly people presenting to one large Australian public
tertiary hospital Emergency Department. Aust Health Rev. in press.
38. Caplan GA, Williams AJ, Daly B, Abraham K: A randomized, controlled trial
of comprehensive geriatric assessment and multidisciplinary intervention
after discharge of elderly from the Emergency Department—the DEED II
study. J Am Geriatr Soc 2004, 52:1417–1423.
39. Russell M, Hill K, Day L, Blackberry I, Gurrin L, Dharmage S: Development of
the falls risk for older people in the community (FROP-Com) screening
tool. Age Ageing 2009, 38:40–46.
40. Folstein MF, Folstein SE, McHugh PR: Mini-mental state: a practical
method for grading the cognitive state of patients for the clinician.
J Psychiatr Res 1975, 12:189–198.
41. Ware JJE, Sherbourne CD: The MOS 36-item short-form health survey
(SF-36). Conceptual framework and item selection. Med Care 1992,
30:473–483.
42. Ware JE, Kosinski M, Keller S: A 12-Item Short-Form Health Survey:
construction of scales and preliminary tests of reliability and validity.
Med Care 1996, 34:220–233.
43. Hawthorne G, Richardson J, Osborne R, McNeil H: The Australian Quality of
Life (AQoL) Instrument: Initial Validation. Working Paper. West Heidelberg:
Australia Centre for Health Program Evaluation; 1997.
44. Paddison J, Cafarella P, Frith P: Use of an Australian Quality of Life tool in
patients with COPD. COPD 2012, 9:589–595.
45. Ziebland S: Why listening to health care users really matters. J Health Serv
Res Policy 2012, 17:68–69.
46. Berwick D: What ‘Patient-Centered’ should mean: confessions of an
extremist. Health Aff 2009, 28:w555–w565.
47. Bouwens S, van Heugten C, Verhey F: Review of goal attainment scaling
as a useful outcome measure in psychogeriatric patients with cognitive
disorders. Dement Geriatr Cogn Disord 2008, 26:528–540.
48. Crotty M, Giles L, Halbert J, Harding J, Miller M: Home versus day
rehabilitation: a randomised controlled trial. Age Ageing 2008, 37:628–633.
doi:10.1186/1745-6215-14-266
Cite this article as: Grimmer et al.: TRialing individualized interventions
to prevent functional decline in at-risk older adults (TRIIFL): study
protocol for a randomized controlled trial nested in a longitudinal
observational study. Trials 2013 14:266.
